The invention relates to a compound of formula (I)
wherein R
1
to R
4
are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES AS CB2 RECEPTOR ANTAGONISTS
申请人:F. Hoffmann-La Roche AG
公开号:EP3041843B1
公开(公告)日:2019-01-02
US9593123B2
申请人:——
公开号:US9593123B2
公开(公告)日:2017-03-14
[EN] NOVEL TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE TRIAZOLO[4,5-D]PYRIMIDINE
申请人:HOFFMANN LA ROCHE
公开号:WO2015032769A1
公开(公告)日:2015-03-12
The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.